Phase 1 Study of Single Agent GBR 1302 in Subjects With HER2 Positive Cancers
Clinical trial NCT02829372 · TERMINATED
Trial details
- NCT number
- NCT02829372
- Sponsor
- Ichnos Sciences SA
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2019-05-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.